Schedule-dependent pulsed paclitaxel radiosensitization for thoracic malignancy

YUHCHYAU YUHCHYAU CHEN; Kishan PANDYA; Peter P KENG; Richard FEINS; Richard RAUBERTAS; Therese SMUDZIN; Joseph ROSENBLATT; Paul OKUNIEFF

doi:10.1097/00000421-200110000-00004

Back

Schedule-dependent pulsed paclitaxel radiosensitization for thoracic malignancy

Conference proceeding

Peer reviewed

Schedule-dependent pulsed paclitaxel radiosensitization for thoracic malignancy

YUHCHYAU YUHCHYAU CHEN, Kishan PANDYA, Peter P KENG, Richard FEINS, Richard RAUBERTAS, Therese SMUDZIN, Joseph ROSENBLATT and Paul OKUNIEFF

American journal of clinical oncology, Vol.24(5), pp.432-437

Translational Research Symposium

2001

DOI: https://doi.org/10.1097/00000421-200110000-00004

PMID: 11586091

Abstract

Pharmacology. Drug treatments

Biological and medical sciences

Treatment. General aspects

Treatment with physical agents

Medical sciences

Antineoplastic agents

Combined treatments (chemotherapy of immunotherapy associated with an other treatment)

Radiation therapy and radiosensitizing agent

Tumors

Metrics

11 Record Views

16 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.219 Cancer Drugs; 1.219.1208 Paclitaxel
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Schedule-dependent pulsed paclitaxel radiosensitization for thoracic malignancy
Creators: YUHCHYAU YUHCHYAU CHEN - Department of Radiation Oncology, James P. Wilmot Cancer Center, University of Rochester, Rochester, New York, United States
Kishan PANDYA - Department of Radiation Oncology, James P. Wilmot Cancer Center, University of Rochester, Rochester, New York, United States
Peter P KENG - Department of Radiation Oncology, James P. Wilmot Cancer Center, University of Rochester, Rochester, New York, United States
Richard FEINS - Department of Radiation Oncology, James P. Wilmot Cancer Center, University of Rochester, Rochester, New York, United States
Richard RAUBERTAS - Department of Radiation Oncology, James P. Wilmot Cancer Center, University of Rochester, Rochester, New York, United States
Therese SMUDZIN - Department of Radiation Oncology, James P. Wilmot Cancer Center, University of Rochester, Rochester, New York, United States
Joseph ROSENBLATT - Department of Radiation Oncology, James P. Wilmot Cancer Center, University of Rochester, Rochester, New York, United States
Paul OKUNIEFF - Department of Radiation Oncology, James P. Wilmot Cancer Center, University of Rochester, Rochester, New York, United States
Publication Details: American journal of clinical oncology, Vol.24(5), pp.432-437
Conference: Translational Research Symposium
Publisher: Lippincott Williams & Wilkins; Hagerstown, MD
Grant note: Radiation Therapy Oncology Group (RTOG)
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Conference proceeding
PMID: 11586091
Record Identifier: 991031561973102976